4th Quarter - Report
BROWNSTEIN HYATT FARBER SCHRECK, LLP for FERRING PHARMACEUTICALS INC.
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
issues related to microbiome, oncology, fertility, and health equity Issues related to formulary tier status NDAA FY24
Foreign entity interest: Ferring Holdings SA and Ferring BV listed on the registration under foreign entities have an interest in health equity.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM DUNHAM | — |
| EMILY FELDER | — |
| ZACHARY PFISTER | — |
| ADAM STEINMETZ | — |
| GREGORY SUNSTRUM | — |
| DEEMA TARAZI New | — |
| JONATHAN TOWERS | — |
| ANDREW USYK | — |
| ARI ZIMMERMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.